24/7 Market News Snapshot 06 June, 2025 – Know Labs, Inc. (NYSE:KNW)
DENVER, Colo., 06 June, 2025 (www.247marketnews.com) – (NYSE:KNW) are discussed in this article.
Know Labs, Inc. is currently witnessing a significant surge in market interest, exemplified by its impressive pre-market trading. The stock has soared to $1.374, reflecting an extraordinary increase of 169.41% from its previous close of $0.510, supported by a robust trading volume of 16.47 million shares. This dramatic rise indicates a rising enthusiasm among investors, likely fueled by the company’s recent strategic developments in health technology.
Further amplifying this momentum, Know Labs has reached a groundbreaking agreement with Goldeneye 1995 LLC, an entity associated with fintech innovator and former Ripple Chief Risk Officer, Greg Kidd. This strategic partnership positions Mr. Kidd to take the helm as Chief Executive Officer and Chairman of the Board upon completion. His vision includes the implementation of a Bitcoin treasury strategy, aimed at providing substantial economic exposure to digital assets, thus enhancing shareholder value through sustainable growth initiatives.
The collaboration will also result in the retirement of existing debt and a boost in the company’s working capital through an innovative structure that combines Bitcoin with cash assistance. Ron Erickson, the founder of Know Labs, will transition to President of a newly formed diagnostic research division and has expressed enthusiasm for the partnership, viewing it as a pivotal moment in the company’s journey.
The Board of Directors has enthusiastically approved the transaction, which is anticipated to finalize in the third quarter of 2025, contingent on shareholder approval and other customary conditions. This alliance is expected to significantly enhance Know Labs’ valuation metrics and solidify its presence in the dynamic health technology sector. With its proprietary, non-invasive medical technology, Know Labs is poised to make substantial strides in delivering accessible and effective healthcare solutions, marking a transformative chapter in its ongoing innovation endeavors.